VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 365 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,237,000 | -17.2% | 225,900 | 0.0% | 0.02% | -25.9% |
| Q2 2017 | $3,908,000 | +56.8% | 225,900 | 0.0% | 0.03% | +50.0% |
| Q1 2017 | $2,492,000 | -24.0% | 225,900 | 0.0% | 0.02% | -25.0% |
| Q4 2016 | $3,280,000 | -40.9% | 225,900 | 0.0% | 0.02% | -38.5% |
| Q3 2016 | $5,546,000 | +21.9% | 225,900 | 0.0% | 0.04% | +25.8% |
| Q2 2016 | $4,550,000 | -23.4% | 225,900 | 0.0% | 0.03% | -22.5% |
| Q1 2016 | $5,941,000 | -74.1% | 225,900 | 0.0% | 0.04% | -75.9% |
| Q4 2015 | $22,963,000 | -43.0% | 225,900 | 0.0% | 0.17% | -47.6% |
| Q3 2015 | $40,296,000 | – | 225,900 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |